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CHRONIC endobronchial  inflammation  and  bacterial
infection  are  the  main  causes  of  morbidity  and
mortality in cystic fibrosis (CF), an autosomal reces-
sive genetic disorder associated with improper func-
tion of chloride channels. Inflammation in CF lung is
greatly  amplified  after  Pseudomonas  aeruginosa
infection.  In this study the relationship between P.
aeruginosa status  and  inflammatory  markers  has
been  investigated.  Seventeen  CF  children  in  acute
lung exacerbation were examined. CF patients with-
out  P.  aeruginosa  infection  were  characterized  by
elevated activity of sputum elastase, reduced response
of  peripheral  blood  lymphocytes  to  PHA  and  sig-
nificant  resistance to the antiproliferative action of
glucocorticoids.  These parameters were  normalized
after  antibiotic  treatment.  The  patients  with  pro-
longed  P.  aeruginosa  infection demonstrated
extremely high levels of elastase activity and elevated
amounts of sputum IL-8 and TNF-a . Although antibi-
otic  treatment  resulted  in  clinical  improvement,  it
failed to suppress excessive immune response in the
lung.  The  data  indicate  that  CF  patients  with  pro-
longed P. aeruginosa need the modified treatment,
which should include immunomodulating drugs and
protease inhibitors as well as antibacterial therapy. 
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Introduction
Cystic fibrosis (CF) is a common, serious, and often
fatal  autosomal  recessive  genetic  disorder,  which
characterized by oversecretion of pulmonary mucus,
bacterial  infections  and  respiratory  congestion. The
CF  gene  codes  for  a  cellular  membrane  protein,
which  forms  a  chloride  channel  and  appears  to
regulate other channel proteins. Improper function of
this channel results in electrolyte abnormalities at the
surfaces of various secretory and resorptive cells.1,2
The absorption of sodium across airway epithelia is
increased  2–3  fold.  As  a  result  of  the  associated
increase in osmotic water absorption, the hydration
of the airway surface liquid is likely to be reduced,
which it is thought affects the mucocilliary clearance
and bacterial adherence. These abnormalities may be
explain why CF patients suffer from respiratory tract
infections;3 at  the  same  time  CF  patients  have  no
detectable  immune  deficiency. They  are  not  more
susceptible  to  infections,  except  those  of  the  the
respiratory tract,  than  normal  children of the  same
age.4 The pulmonary infections incite an intense host
inflammatory  response,  causing  progressive  suppu-
rative  pulmonary  disease. This  response  is  charac-
terized  by  a  marked  influx  of  neutrophils  into  the
lung, and elevation in inflammatory mediators such as
TNF-a , IL-1b , IL-6, IL-8, and leukotriene B4.5,6 As a rule
CF patients suffer from recurrent and chronic endo-
bronchial  Pseudomonas  aeruginosa infections
which  are  very  serious  in  terms  of  clinical  prog-
nosis.7,8 There are different phases of P. aeruginosa
colonization. Initial pathogen colonization is charac-
terized by selection of alginate (mucoid) producing
mutants  and  a  biofilm  formation. The  next  stage  is
characterized  by  the  appearance  of  new  mucoid
microcolonies, decreased production of extracellular
virulence  factors  and  minimal  tissue  damage.  A
terminal  phase  is  manifested  in  high  bacterial  cell
density,  elevated  release  of  extracellular  virulence
factors and massive tissue damage.9 In this article we
describe  the  relationship  between  the  period  of  P.
aeruginosa infection and several inflammatory mark-
ers in CF pediatric patients.
Material  and  methods
Patient  assessment
Seventeen  CF  children  (mean  age  12  years)  were
recruited for the study. They were lung exacerbation
patients from the Department of Cystic Fibrosis of the
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patients showed variable disease severity and differ-
ent  P.  aeruginosa status.  Five  subjects  were  not
colonized  with  the  pathogen  and  twelve  children
were infected with mucoid strains of P. aeruginosa.
The last group of patients included four individuals
who had been colonized with P. aeruginosa for less
than  two  years  (short-term  infection)  and  eight
children colonized for two years or more (prolonged
infection). The diagnosis of acute pulmonary exacer-
bation was defined as a marked increase in C reactive
protein, by  weight loss,  anorexia,  increased  cough,
increased sputum production, fever with and without
new  lung  infiltrates,  and  deterioration  of  oxygen
saturation  and  pulmonary  function.  The  following
pulmonary  function  tests  were  performed:  forced
vital capacity; forced expiratory volume and oxygen
saturation measurements after a walking test. Patients
with  acute  pulmonary  exacerbation  were  treated
with  basic  therapy  (microspheric  enzymes,  multi-
vitamins,  high  calorie  diet,  mucolytics)  and  anti-
biotics.  Antibacterial  treatment  depended  on  the
microbiology  analysis  of  sputum.  In  the  case  of  P.
aurogenosa infection, cephalosporins of 3rd genera-
tion  in  combination  with  aminoglycosids  or  cipro-
floxacin were prescribed.
Blood  collection  and  sputum  processing
Blood was collected in tubes with heparin (25 IU/ml)
by venipuncture. The weight of each sputum sample
was calculated. The same weight of PBS without Ca2+
and  Mg2+ was  added  to  the  sputum  sample.  The
mixture  was  placed  on  vortex  for  10  seconds  and
then on the rocker for 30  min. The sample filtered
through a 100 m m filter to remove mucus. The filtrate
has been centrifuged at  400 g for 10 min at 4°C to
pellet the cells. Protein concentration was measured
using  Bradford’s  method.10,11 The  supernatant  was
then removed, aliquoted and stored at –60°C.
Assay  of  human  leucocyte  elastase
The  assay  method  used  is  based  on  the  ability  of
neutrophil  elastase  to  interact  with  the  specific
chromogenic  BANE  (N-t-Boc-L-alanine  p-nitrophenyl
ester)  (Reanal,  Hungary)  at  acidic  pH  forming
p-Nitrophenol with maximum of absorbance at 347.5
nm.12,13 The standard assay was performed in 0.6 ml
of a solution containing an aliquot of sputum sample
(20–200 m l), 0.01 M BANE (20 m l) and 0.05 M sodium
phosphate at 24°C and pH 6.5. Probes were assayed
for  absorbance  at  347.5  nm  for  12–15 min. Absor-
bance per minute was then accounted. The amount of
elastase was calculated using formula:
Elastase activity (U/ml) = D347.53 109/V
where D347.5 = absorbance per minute; V = volume of
the sputum aliquot added; 109 is a parameter which
includes  extinction  coefficient,  the  length  of  light
path,  and  volume  of  the  reaction  mixture.  Under
these  conditions  one  unit  of  human  neutrophil
elastase activity was that amount which hydrolyzed 1
nM  of  BANE  per  minute.  Finally  the  value  of  neu-
trophil elastase activity was normalized to the protein
content in each sample of the sputum extract.
Inhibition  of  PHA-induced  lymphocyte
proliferation  by  dexamethasone
Mononuclear  cells  were  isolated  from  heparinazed
peripheral  blood  by  Ficoll-Verographin  density  gra-
dient centrifugation. The cells were washed twice in
RPMI-1640  medium (ICN,  USA)  supplemented  with
10% heat-inactivated donor horse serum, 23 10–3 M
HEPES, 2 mM L-glutamine, 2.83 10–6 M 2-mercaptoe-
thanol,  and  20  m g/ml  gentamycin. The  cells  were
cultivated  in  flat-bottomed  96-well  plates  (Costar,
USA),  and  contained  53 104 cells  in  each  well. The
final concentration of PHA (Sigma, USA) was 5m g/ml.
Inhibition of PHA stimulation by dexametasone (Dm)
was evaluated at six different concentrations within
the dose range of 10–10 to 10–6 M. Dm was not added
to  the  control  wells  (these  contained  a  culture
medium  with  or  without  PHA).  The  cells  were
incubated for 72h at 37°C in humidified atmosphere
containing  5%  CO2.  Four  hours  before  the  end  of
cultivation,  each  well  was  pulsed  with  40  kBq  of
[3H]-thymidine  (Isotope,  Russia).  The  cells  were
harvested  with  a  cell  harvester  and  counted  on  a
liquid  scintillation  counter. Triplicate  wells  of  each
concentration  were  assayed  and  the  counts  per
minute  (count/min)  were  averaged.  Percentage
inhibition was calculated by dividing the count/min
in  each  inhibited  sample  by  the  count/min  in  the
sample  containing  PHA  only,  and  subtracting  the
background  level  (counts/min  in  the  wells  with
culture medium only) from these values. The intensity
of suppression was estimated by probit-analysis and
expressed  as  ED50:  a  dose  of  immunosuppressive
agent at which lymphocyte proliferation was 50% of
its maximum. Previously the direct positive correla-
tion between the level  of PHA-induced lymphocyte
proliferation  and  of  the  inhibition  degree  of  such
stimulation  by  dexamethasone  (ED50)  has  been
shown. On the basis of this correlation we proposed
the method of evaluation of individual susceptibility
to  the  antiproliferative  effect  of  glucocorticoids  by
D h-parameter calculation.14
D h was calculated using formula:
D h = Y – Y9
where Y = logED50; Y9 = 0.447X – 4.399; X = ln(count
per min).
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TNF activity was determined by the method of Ruff
and Gifford15 with some modifications. Briefly, L929
cells  were  seeded  at  a  density  of  33 104 cells  per
well in 96-well plates in  100 m l of medium 199, to
which  10%  heat  inactivated  calf  bovine  serum  and
gentamycin  had been added. Plates were incubated
at  37°C  in  a  humidified  atmosphere  containing  5%
CO2 until  monolayer  formation.  After  the  culture
medium  elimination,  two-fold  serial  dilution  of  the
samples (100  m l of each dilution) and 100  m l fresh
culture  medium  with  20  m g/ml  of  actinomycin  D
(Serva,  Germany)  were  added,  and  further  incu-
bated for 18 h in the same conditions. Supernatants
were  then  removed  and  cells  stained  with  0.2%
crystal  violet  (Sigma,  USA). After  washing  and  dry-
ing plates were finally read at 595 nm on a Titertek
Multiskan  microElisa  reader.  Human  recombinant
TNF-a (Institute  of  Bioorganic  Chemistry,  Moscow,
Russia)  was  used  as  internal  standard. The  probit-
analysis method was used for the comparison of the
experimental and calibrating curves. TNF content in
the  samples  was  expressed  in  pg/ml  and  was  nor-
malized  to  the  protein  content  in  each  sputum
sample.
IL-8 was determined in the sputum samples using
a commercially available ELISA  (Proteinovyi  Kontur,
St  Petersburg, Russia)
Statistical  analysis
Statistical  analysis  was  performed  using  Student’s
t-test. Correlation between elastase activity and forced
vital  capacity  was  analyzed  using  Spearman  rank
correlation.
Results
Neutrophil  elastase  activity  in  the  sputum  of  CF
patients
During acute pulmonary exacerbation all CF patients
exhibited elevated levels of neutrophil elastase activ-
ity  (Fig.  1). The  elastase  activity  in  the  sputum  of
patients  with  short-term  P.  aeruginosa infection
appeared to be at or below the protease amount in
the sputum of uninfected subjects (8.1 ± 1.7 U/mg
protein and 10.7 ± 1.5 U/mg, respectively, p = 0.3). In
contrast, CF patients with prolonged  P.  aeruginosa
infection  demonstrated  extremely  large  protease
amounts in their sputum samples. Elastase activity in
these patients was significantly higher than those in
two other patient groups (34.7 ± 5.5 U/mg, p< 0.003).
Following the antibiotic therapy the measurements of
elastase activity  revealed  that  protease  amount  was
markedly decreased in the sputum of P. aeruginosa
free  patients  (2.2  ±  0.6  U/mg,  p< 0.03)  and  in
individuals with short-term infection (4.7 ± 1.2 U/mg,
p< 0.02). At the same time, antibiotic administration
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FIG.  1.  Neutrophil  elastase  activity  in  the  lung  of  CF  patients  before  and  after  antibiotic  treatment.,  Sputum  samples  from  CF
patients with different P. aeruginosa status were  assessed for protease presence as described in Materials and Methods.
Results  are  given  as  units  of  elastase  activity  per  mg  protein  and  expressed  as  mean  ±   SEM.  A  two  sample  Student’s  t-test  was
used  to  compare  the  means  of  elastase  activity  in  separate  patient  groups  before  and  after  antibiotic  treatment  (p1,4 <0.03;  p2,5
<0.02).  Differences  in  elastase  activity  levels  between  patient  groups  were  analyzed  using  paired,  two-tailed  Student’s  t-test
(p1,3 <0.003;  p4,6 <0.02).failed  to  suppress  elevated  elastase  activity  in  the
sputum from patients with prolonged P. aeruginosa
infection. Protease activity was increased 10–20 fold
compared with patients with short-term colonization
and  uninfected  subjects.  The  neutrophil  elastase
expression in CF patients was highly correlated with
the lung function failure (Fig. 2). A significant negative
linear association was found between values of forced
vital capacity and lung elastase activity (R = –0.536;
p< 0.04).
IL-8  concentrations  in  the  sputum  of  CF
patients
As  can  be  seen  in  Fig.  3,  a  statistically  significant
elevation  of  IL-8  concentration  in  sputum  samples
from patients with prolonged P. aeruginosa infection
compared with uninfected patients  has been found
(7.3  ±  0.6  ng/mg  protein  and  3.7  ±  0.7  ng/mg,
respectively;  p =  0.02).  Patients  with  short-term  P.
aeruginosa infection exhibited IL-8 levels similar to
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FIG.  2.  Association  betweeen  lung  elastase  activity  and  forced  vital  capacity  (FVC)  in  CF  patients.  The  relationships  between
protease  activity  and  FVC  were  analyzed  by  using  Spearman  rank  correlation  (R =  ± 0.536;  p <0.04).
FIG.  3.  IL-8  concentrations  in  the  sputum  of  CF  patients  during  exacerbation  treatment.  Sputum  samples  were  obtained  from
CF  patients  before  and  after  antibiotic  treatment  and  assessed  for  IL-8  content  by  ELISA.  Values  were  normalized  to  sputum
protein  concentrations  and  represent  the  average  ±   standard  deviation.  An  umpaired,  two-tailed  Student’s  t-test  (p1,3 =  0.02;
p4,6 =  0.29).those observed in children with prolonged coloniza-
tion, but there were no marked differences between
this group and uninfected patients (6.7 ± 1.8 ng/mg, p
= 0.2). Antibiotic treatment did not induce significant
alteration in IL-8 levels in patients with short-term (8.5
± 2.2 ng/mg, p = 0.55) or prolonged colonization (5.13
± 0.9 ng/mg, p = 0.19), as well as in uninfected patients
(3.8 ± 0.8 ng/mg, p = 0.97). However, the cytokine
concentrations in the sputum samples from P. aerugi-
nosa-free children and patients with prolonged coloni-
zation, became statistically equivalent.
TNF-a and  protein  concentrations  in  the
sputum  of  CF  patients
Due to large individual variations, the measurements
of TNF-a concentrations  did  not  reveal  statistically
significant  differences between patient  groups (Fig.
4).  Prior  to  antibiotic  administration  the  median
cytokine levels detected in the sputum of uninfected
subjects, patients with short-term coclonization and
children with prolonged P. aeruginosa infection were
48 pg/mg protein, 13 pg/mg and 770 pg/mg, respec-
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FIG.  4.  TNF-a levels  in  the  lungs  of  CF  patients  with  different  P.  aeruginosa status.  Sputum  samples  were  obtained  from  CF
patients  before  and  after  antibiotic  treatment.  A  cytokine  concentration  was  determined  using  the  biological  test  as  described
in Material  and  Methods.  Median  values are indicated  by the lines. Each dot represents one patient.  Data reported were
compared by unpaired, two-tailed Student’s t-test. There were no statistically significant differences between patient
groups.
FIG.  5.  Protein  concentrations  in  the  sputum  samples  from  CF  patients  during  exacerbation  treatment.  Determination  of  protein
amount  was  performed  by  Bradford’s  method.  Data  reported  were  compared  by  unpaired,  two-tailed  Student’s  t-test.  There
were  no  statistically  significant  differences  between  patient  groups.  Symbols  as  in  Fig.  4.tively. Antibiotic treatment had no significant effect on
TNF-a levels in all patient groups. Thus, lowest TNF-a
level  (17.3  pg/mg)  in  the  sputum  samples  of  CF
patients  with  short-term  infection  has  been  found.
Uninfected subjects showed intermediate concentra-
tions  of  the  cytokine  (46.4  pg/mg).  Patients  with
prolonged P. aeruginosa infection demonstrated the
highest levels of the sputum TNF-a (2539.8 pg/mg) as
before  treatment. The  protein  levels  in  the  sputum
samples from CF patients with different P. aeruginosa
status have been analyzed (Fig. 5). During acute lung
exacerbation, the patients with short-term P. aerugi-
nosa  infection  and  uninfected  CF  subjects  showed
comparable protein contents (median 1.02mg/ml and
0.88 mg/ml,  respectively).  Antibiotic  administration
did  not  influence  on  the  protein  concentration  in
uninfected  children  (0.84 mg/ml)  and  moderately
decreased  protein  levels  in  the  sputum  of  patients
with  short-term infection  (0.51 mg/ml). In  contrast,
the  most  sputum  samples  from  patients  with  pro-
longed P. aeruginosa  infection  contained  increased
protein  amount  (1.49mg/ml),  which  markedly  ele-
vated after antibiotic treatment (2.77 mg/ml). Despite
of the visible distinctions in protein levels, statistical
comparison  did  not  reveal  significant  differences
between the patients groups.
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Table  1.  Effect  of  antibiotic  treatment  on  PHA-induced  peripheral  blood  lymphocyte  proliferation.  Data  are  presented  as  mean
±   SEM
Patients Proliferative  response  (count  per  min)
Before  treatment After  treatment
Without  P.  aeruginosa (n =  5) 61002  ±   10439 103122  ±   15473*
With  short-term  P.  aeruginosa infection  (n =  4) 100226  ±   26936 920023  ±   23292
With  prolonged  p.  aeruginosa infection  (n =  7) 90374  ±   20465 70269  ±   20712
*P <0.02,  two  samples  Student’s  t-test.
FIG.  6.  Peripheral  blood  lymphocyte  (PBL)  susceptibility  to  antiproliferative  effect  of  dexamethasone  in  CF  patients.  Inhibition
degree of PHA-induced lymphocyte proliferation by different concentrations of dexamethasone was evaluated. The cell
sensitivity is presented as a mean of D h values (see Material and Methods). The asterisk indicates the D h values in P.
aeruginosa-free  patients  before  and  after  antibiotic  treatment  are  significantly  different  (p <0.05;  two  sample  Student’s  t-test),
i.e.  after  treament  PBL  became  more  sensitive  to  glucocorticoid  hormones.Proliferative  response  to  PHA  and  lymphocyte
susceptibility  to  glucocorticoids
There were no significant differences in the levels of
proliferative  response  between  all  patient  groups
(Table 1). Antibiotic administration did not induce any
alteration in T cell proliferative response in P. aerugi-
nosa infected patients. At the same time PHA-induced
proliferation  of  lymphocytes  from  uninfected  sub-
jects,  lower  at  exacerbation,  was  significantly
increased after antibiotic treatment (p< 0.02).
To  evaluate  individual  susceptibility  to  glucocor-
ticoids, the D h-parameters were accounted as descri-
bed in ‘Material and Methods’. Patients were classified
as  steroid  resistant  if  their  D h-parameters  increased
> 0  and  steroid  sensitive  if  this  parameter  failed  to
increase > 0 (Fig. 6). During the acute lung exacerba-
tion peripheral blood lymphocytes obtained from CF
patients uninfected with P. aeruginosa demonstrated
the resistance to antiproliferative action of Dm (D h =
0.34 ± 0.26). In contrast, the patients with short-term
and  prolonged  P.  aeruginosa  infections  were  rela-
tively steroid-sensitive (D h = –0.05 ± 0.36 and D h =
–0.02  ±  0.14,  respectively). After  antibiotic  admin-
istration, uninfected children showed the switch from
steroid-resistance to steroid-sensitivity (D h = –0.54 ±
0.22, p< 0.02). Patients with short-term P. aeruginosa
infections tended to show higher responsiveness to
Dm  (D h =  –0.39  ±  0.28).  The  D h-parameters  in
individuals  with  prolonged  P.  aeruginosa  infection
were of intermediate values and did not significantly
differ from those before antibiotic administration (D h
= 0.04 ± 0.18, p = 0.78).
Discussion
During  the  first  years  of  life,  young  children  with
CF  are  colonized  and  develop  pneumonia  second-
ary  to  Staphylococcus  aureus,  Haemophilus  influ-
enzae, or  less  commonly,  Klebsiella  pneumoniae.
These infections are relatively easy to treat with the
appropriate  antibiotics.16,17 In  our  study  the  acute
lung exacerbation in P. aeruginosa-free CF patients
was  associated  with  Staphylococcus  aureus infec-
tion  and  characterized  by  elevated  activity  of  spu-
tum elastase, reduced response of peripheral blood
lymphocytes  to  PHA  and  significant  resistance  to
antiproliferative  action  of  glucocorticoids.  Such
resistance  is  associated  with  acute  lung  inflamma-
tion  and  is  accompanied  by  the  large  numbers  of
activated  lymphocytes  producing  elevated  amounts
of  IL-2.  Following  successful  antibiotic  treatment,
reduction  of  the sputum elastase activity,  increased
peripheral  blood  lymphocyte  response  to  PHA,  as
well  as  the  change  from  steroid  resistance  to  ster-
oid  sensitivity  of lymphocytes  have been  observed.
In  this  patient  group  normalization  of  laboratory
parameters  was  strongly  related  to  evident  clinical
improvement.
Although  sputum  amounts  of  active  elastase
decreased  five-fold  after  antibiotic  treatment,  com-
plete  inhibition  of  protease  activity  did  not  occur.
In  addition,  antibiotics  did  not  affect  the  elevated
concentrations  of  IL-8  in  the sputum. It  is possible
that  the  stable  elevation  of  the  cytokine  is  asso-
ciated  with  CF  pathogenesis.  It  is  known  that  the
NaCl  concentration  in  CF  bronchial  secretion  liq-
uids  is  higher  than  that  found  in  normal  sub-
jects.18 –20 High NaCl concentrations may contribute
to a prolonged inflammatory state by releasing high
amounts of IL-8 from CF airway submucosal glands.
Consequently,  neutrophils  activated  by  locally
secreted  IL-8  release  elastase  and  oxidants  that
stimulate  airway  surface  epithelial  cells  to  produce
other chemotactic  factors, such as TNF-a , IL-1b , IL-
6, and IL-8,21,22 which may generate and perpetuate
an  inflammatory  vicious  cycle  in  CF  airways. This
inflammation  can  be  amplified  after  P.  aeruginosa
infection.23
In most CF patients P. aeruginosa colonization is
initiated  by  nonmucoid  strains.  Hyperosmolar  envi-
ronment of the CF airways as well as oxygen radicals
produced by the inflammatory response induce the
phenotypic  change  from  non-alginate  producing  to
alginate (mucoid) producing phenotypes of P aeru-
ginosa.24 –26 Alginate, unbranched linear heteropoly-
saccharide, is a significant  virulence factor. Initially,
a  mucoid  coat  is  produced  around  single  bacteria
and later surrounds several micro-colonies of bacte-
rial  cells.  It  has  been  shown  in  vitro,  that  P.
aeruginosa growing  in  alginate  producing  micro-
colonies (biofilms) is highly resistant to opsonic and
nonopsonic  phagocytosis,27 complement,28 reactive
oxygen  intermediates29,30 and  antibiotics.31,32 Bio-
film  bacteria  behave  as  a  population  instead  of
individual cells.32,33 They are  able to  estimate  their
own cell density, interact with each other and react
appropriately to environment changes. This phenom-
enon is termed quorum-sensing or cell-to-cell signal-
ing.34,35 P. aeruginosa biofilms appear to coordinate
expression  of  virulence  genes  and  control  the  pro-
duction  of  many  extracellular  virulence  factors  by
quorum-sensing  systems.  A  specific  transcriptional
activator of virulence gene expression (R-protein) is
not active without the corresponding autoinducer.34
The latter is synthesized at basal levels and diffuses
into the surrounding media. At low cell density, the
intracellular  concentration  of  autoinducer  is  not
enough  to  activate  a  specific  R-protein.  So  the
intensity  of  virulence  gene  transcription  and,  as  a
consequence,  production  of  extracellular  virulence
factors are also low. With increasing cell density the
intracellular amount  of  autoinducer  reaches  critical
concentration for a specific R-protein activation. The
resulting  increase  in  expression  of  virulence  genes
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rial  exoproducts  initiates  exuberant  host  immune
response,  including  excessive  production  of  proin-
flammatory  cytokines  and  neutrophil  recruitment
with large amounts of elastase being released.9 It is
precisely  this  fact  that  explains  serious  pulmonary
destruction in CF patients colonized with P. aerugi-
nosa.36 No wonder the appropriate antibiotic thera-
pies  are  often  unable  to  stop  this  course.  This
situation  was  clearly  demonstrated  in  our  study.
Thus,  extremely  high  elastase  activity,  elevated
amount  of  IL-8  and  TNF-a ,  as  well  as  increased
protein  concentrations,  have  been  observed  in  the
sputum  samples  from  examined  CF  patients  with
prolonged  P.  aeruginosa  infection.  It  appears  that
entire biofilm in airways of these patients produces
enough  amount  of  autoinducer  to  initiate  elevated
production  of virulence  factors. Although antibiotic
treatment  resulted in clinical improvement, it  failed
to suppress excessive immune response in the lung.
By  contrast,  an  immature  P.  aeruginosa biofilm  in
patients with short-term infection is not a source of
virulence  factors.  In  addition,  the  alginate  coat
prevents contacts of the host’s defense systems with
bacteria.  For  this  reason  inflammatory  response  in
the  patients  was  comparable  to  that  in  uninfected
children.  Lung  exacerbation  in  patients  with  short-
term  colonization  and  P.  aeruginosa-free  subjects
was associated with acute S. aureus infection, which
was  successfully  treated  with  antibiotics.  All  CF
patients  with  P.  aeruginosa infection  (prolonged
and  short-term)  demonstrated  high  IL-8  levels  in
comparison with uninfected individuals (see Fig. 3)
that may be explained by influence of P. aeruginosa
products  (e.g. alginate) on airway epithelial cells.22
Relatively  low  lymphocyte  sensitivity  to  the  anti-
proliferative effects of glucocorticoids (D h about 0) in
P. aeruginosa-infected patients is evidence of perma-
nent  inflammation  in  airways.  The  switch  from
resistance  to  sensitivity  in  patients  with  short-term
colonization,  shows  that  the antibiotic  treatment  is
able to suppress the inflammation. The same suppres-
sion is impossible in the subjects with prolonged P.
aeruginosa infection (see Fig. 6).
Our  data  suggest  that  CF  patients  chronically
infected with P. aeruginosa, especially the subjects
with  prolonged  colonization,  need  the  modified
approach  to  their  treatment. This  approach  has  to
include, besides antibacterial therapy, immunomodu-
lating  drugs  and  protease  inhibitors.  The  first  are
intended  for  the  inhibition  of  excessive  immune
response  and  the  second  are  necessary  to  prevent
neutrophil elastase-mediated pulmonary destruction.
The  novel  strategy  of  CF  treatment  also  requires
permanent  immunological  monitoring  with  evalu-
ation of neutrophil elastase activity and proinflamma-
tory  cytokine  levels  in  the  sputum  samples  of  CF
patients.
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